| __timestamp | Ligand Pharmaceuticals Incorporated | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 55402000 | 116287000 |
| Thursday, January 1, 2015 | 66107000 | 136004000 |
| Friday, January 1, 2016 | 103402000 | 203017000 |
| Sunday, January 1, 2017 | 135736000 | 287023000 |
| Monday, January 1, 2018 | 245116000 | 393541000 |
| Tuesday, January 1, 2019 | 108935000 | 376095000 |
| Wednesday, January 1, 2020 | 156000000 | 467938000 |
| Friday, January 1, 2021 | 214957000 | 504714000 |
| Saturday, January 1, 2022 | 143418000 | 580017000 |
| Sunday, January 1, 2023 | 96265000 | 523742000 |
Unleashing the power of data
In the ever-evolving pharmaceutical industry, understanding financial trends is crucial. Over the past decade, Ligand Pharmaceuticals Incorporated and Supernus Pharmaceuticals, Inc. have shown distinct trajectories in their gross profit margins. From 2014 to 2023, Supernus Pharmaceuticals consistently outperformed Ligand, with a peak gross profit in 2022 that was nearly four times higher than Ligand's. Notably, Supernus saw a remarkable 400% increase in gross profit from 2014 to 2022, while Ligand's growth was more modest, peaking in 2018 before experiencing fluctuations.
The data reveals that Supernus's strategic initiatives and market positioning have paid off, especially in the latter half of the decade. Meanwhile, Ligand's performance, though steady, highlights the challenges of maintaining growth in a competitive landscape. As we look to the future, these trends offer valuable insights into the financial health and strategic direction of these pharmaceutical giants.
Pfizer Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Gilead Sciences, Inc. vs Ligand Pharmaceuticals Incorporated
Takeda Pharmaceutical Company Limited and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Alnylam Pharmaceuticals, Inc. or Supernus Pharmaceuticals, Inc.
Who Generates Higher Gross Profit? Biogen Inc. or Ligand Pharmaceuticals Incorporated
Key Insights on Gross Profit: Catalent, Inc. vs Ligand Pharmaceuticals Incorporated
Gross Profit Trends Compared: Catalent, Inc. vs Supernus Pharmaceuticals, Inc.
Ascendis Pharma A/S vs Supernus Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: Amneal Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. Trends
Key Insights on Gross Profit: Veracyte, Inc. vs Ligand Pharmaceuticals Incorporated
HUTCHMED (China) Limited and Supernus Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Supernus Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.